Arrowhead Pharmaceuticals Inc. buy Bank of America Co.
Start price
04.12.23
/
50%
€21.76
Target price
04.12.24
€26.71
Performance (%)
-7.81%
Price
06.09.24
€20.06
Summary
This prediction is currently active. With a performance of -7.81%, the BUY prediction for Arrowhead Pharmaceuticals Inc. by Bank_of_America_Co_ is down slightly. This prediction currently runs until 04.12.24. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | -6.957% | -6.957% |
iShares Core DAX® | -3.429% | 5.085% |
iShares Nasdaq 100 | -6.121% | 0.593% |
iShares Nikkei 225® | -7.364% | 5.479% |
iShares S&P 500 | -4.366% | 2.019% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $29.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€28.47
02.01.24
02.01.24
€33.76
02.01.25
02.01.25
-29.54%
06.09.24
06.09.24